Influence of the glycosaminoglycan layer on the permeation of hypericin in rat bladders in vivo

BJU International

Volumn 100, Issue 5, 2007, Pages 1176-1181

  Huygens, Ann ^a   Crnolatac, Ivo ^a   Maes, Jan ^a   Van Cleynenbreugel, Ben ^b   Van Poppel, Hendrik ^b   Roskams, Tania ^b   De Witte, Peter A M ^a  

^a Faculteit Farmaceutische Wetenschappen   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Bladder; GAG layer; Hypericin; Permeation

Indexed keywords

CHONDROITIN ABC LYASE; DODECYL BETA DEXTRO MALTOSIDE; DODECYL SULFATE SODIUM; GLYCOSAMINOGLYCAN; HYPERICIN; PHOTOSENSITIZING AGENT; PROTAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER PERMEABILITY; BLADDER WALL; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; FROZEN SECTION; IMAGE ANALYSIS; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; RAT; SUPERFICIAL CANCER; UROGENITAL TRACT CANCER; UROTHELIUM;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; FEMALE; GLYCOSAMINOGLYCANS; MICROSCOPY, FLUORESCENCE; PERYLENE; PHOTOSENSITIZING AGENTS; RATS; RATS, INBRED F344; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 35148813618     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07167.x     Document Type: Article

References (28)

1. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002 38 : 99 166
2. Hudson MA. When intravesical measures fail. Indication for cystectomy in superficial disease. Urol Clin N Am 1992 19 : 601 9
3. Shackley DC, Whitehurst C, Moore JV, George NJR, Betts CD, Clark NW. Light penetration in bladder tissues. implication for the intravesical photodynamic therapy of bladder tumours. BJU Int 2000 86 : 638 43
4. Dougherty JT, Marcus SL. Photodynamic therapy. Eur J Cancer 1992 28 : 1734 42
5. Lavie G, Mazur Y, Lavie D, Meruelo D. The chemical and biological properties of hypericin: a compound with a broad spectrum of biological activities. Med Res Rev 1995 15 : 111 9
6. D'Hallewin MA, Kamuhabwa AR, Roskams T, de Witte PAM, Baert L. Hypericin-based fluorescence diagnosis of bladder carcinoma. BJU Int 2002 89 : 760 3
7. Olivo M, Lau W, Manivasager V, Tan PH, Soo KC, Cheng C. Macro-microscopic fluorescence of human bladder cancer using hypericin fluorescence cystoscopy and laser confocal microscopy. Int J Oncol 2003 23 : 983 90
8. Duran N, Song PS. Hypericin and its photodynamic action. Photochem Photobiol 1986 43 : 677 80
9. Kraus GA, Zhang WJ, Fehr MJ, Petrich KW, Wannemuehler Y, Carpenter S. Research at the interface between chemistry and virology: development of a molecular flashlight. Chem Rev 1996 1 : 523 35
10. Diwu Z, Lown JW. Photosensitization with anticancer agents. 17. EPR studies of photodynamic action of hypericin: formation of semiquinone radical and activated oxygen species on illumination. Free Rad Biol Med 1993 14 : 209 15
11. Hamilton G. Multicellular spheroids as an in vitro tumor model. Cancer Lett 1998 131 : 29 34
12. Kunz-Schughart LA, Kreutz M, Knuechel R. Current status review: multicellular spheroids: a three-dimensional in vitro culture system to study tumour biology. Int J Exp Path 1998 79 : 1 23
13. Huygens A, Kamuhabwa AR, Roskams T, Van Cleynenbreugel B, Van Poppel H, de Witte PAM. Permeation of hypericin in spheroids composed of different grade transitional cell carcinoma cell lines and normal human urothelial cells. J Urol 2005 174 : 69 72
14. Hurst RE. Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract. World J Urol 1994 12 : 3 10
15. Hurst RE, Zebrowski R. Identification of proteoglycans present at high density on bovine and human bladder luminal surface. J Urol 1994 152 : 1641 4
16. Mazur Y, Meruelo D. Ion pairs of hypericin compounds having antiviral activity. (Patent Cooperation Treaty). WO 93/15607 1993
17. De Klerk P. The glycosaminoglycans of human bladder cancers of varying grade and stage. J Urol 1985 134 : 978 81
18. Falk H, Oberreiter M. A convenient semisynthetic route to hypericin. Monatsh Chem 1993 124 : 339 41
19. Kamuhabwa AR, Cosserat-Gerarding I, Didelon J et al. Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy. Int J Cancer 2002 97 : 253 60
20. Wilson CB, Leopard J, Cheresh DA, Nakamura RM. Extracellular matrix and integrin composition of the normal bladder wall. World J Urol 1996 14 : S30 7
21. Rübben H, Friedrichs R, Stuhlsatz HW, Lutzeyer W. Glycosaminoglycans in urothelial carcinomas. Urol Res 1983 11 : 163 6
22. Kuwahara M, Tokiwa M, Orikasa S. Bacterial infection and acid mucopolysaccharides in epithelium of rat urinary bladder. Urol Res 1982 10 : 93 6
23. Mostafavi M, Stein PC, Parsons CL. Production of soluble virulence factor by Escherichia coli. J Urol 1995 153 : 1441 3
24. Derycke ASL, Kamuhabwa A, Gijssens A et al. Transferrin-conjugated liposome targetin of photosensitizer AlPcS4 to rat bladder carcinoma cells. J Natl Cancer Inst 2004 96 : 1620 30
25. Ramesh N, Memarzadeh B, Ge Y et al. Identification of pretreatment agents to enhance adenovirus infection of bladder epithelium. Mol Ther 2004 10 : 697 705
26. Min G, Zhou G, Schapira M, Sun TT, Kong XP. Structural basis of urothelial permeability barrier function as revealed by Cry-EM studies of the 16 nm uroplakin particle. J Cell Sc 2003 116 : 4087 94
27. Li SM, Zhang ZT, Chan S et al. Detection of circulating uroplakin positive cells in patients with transitional cell carcinoma of the bladder. J Urol, 1999 162 : 931 5
28. Moll R, Wu SR, Lin JH, Sun TT. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas. Am J Pathol 1995 147 : 1383 97